Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

PRP Injection for Thumb Base Osteoarthritis (CMC-I) to See if It Reduces Pain

Official title: Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (Thumbs-up Study)

Run by Goed Medisch Centrum · NCT07491302 · Data updated 2026-11-12

A PRP injection into the thumb base joint is being tested against a saline injection to see if it lowers pain and improves hand function for adults with thumb base osteoarthritis.

More Thumb Osteoarthritis trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment88 (estimated)
SponsorGoed Medisch Centrum
Academic / other
Locations1 site (Breda, North Brabant)
StatusRecruiting
StartedMay 20, 2026
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedOctober 5, 2026
Trial IDNCT07491302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with Eaton-Littler I–III thumb CMC joint osteoarthritis who have not improved with conservative therapy.

Probably not a fit

Patients with advanced degenerative changes (Eaton-Littler IV), active infection, or other hand joint diseases may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 trial compares a single ultrasound-guided platelet-rich plasma injection with a saline placebo in adults with thumb base (CMC-I) osteoarthritis. Participants will be followed for 12 months with visits at 3, 6, 9, and 12 months to assess pain, hand function, grip and pinch strength, thumb motion, and joint characteristics on ultrasound. The study aims to determine whether PRP can reduce pain and improve hand function compared to placebo and to monitor any adverse events. Eligible participants have non-severe CMC-I OA and have not responded to initial conservative therapy.

Why it matters

Potential benefit: If successful, PRP could offer a less invasive option to reduce pain and improve hand function for thumb base osteoarthritis.

How similar studies have gone: Prior studies in similar joints have shown mixed or variable results; this trial adds controlled, blinded comparison to saline.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or older
* Patients with an Eaton-littler score of I, II or III
* Patients with uni- or bilateral CMC-I osteoarthritis
* Non-responders to conservative therapy i.e., hand therapy and immobilisation after 3 months

Exclusion Criteria:

* Aged below 18
* Patients with an Eaton-littler score of IV (STT arthrosis)
* Surgical interventions of the CMC-I joint
* A known articular systemic disease (e.g. rheumatoid arthritis) or additional hand osteoarthritis/ tenosynovitis or metabolic disease like diabetes mellitus
* Patients with an infectious arthritis of CMC-I joint
* A known psychiatric condition
* Neuropathic chronic pain syndrome
* Intra articular injection 6 months prior to inclusion
* Smoking
* Active use of statins

Where it's running

  • GOED Medisch Centrum
    Breda, North Brabant, Netherlands
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.